161 related articles for article (PubMed ID: 10656807)
1. Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability.
Buschmann T; Minamoto T; Wagle N; Fuchs SY; Adler V; Mai M; Ronai Z
J Mol Biol; 2000 Jan; 295(4):1009-21. PubMed ID: 10656807
[TBL] [Abstract][Full Text] [Related]
2. JNK targets p53 ubiquitination and degradation in nonstressed cells.
Fuchs SY; Adler V; Buschmann T; Yin Z; Wu X; Jones SN; Ronai Z
Genes Dev; 1998 Sep; 12(17):2658-63. PubMed ID: 9732264
[TBL] [Abstract][Full Text] [Related]
3. p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation.
Buschmann T; Adler V; Matusevich E; Fuchs SY; Ronai Z
Cancer Res; 2000 Feb; 60(4):896-900. PubMed ID: 10706102
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
Llanos S; Clark PA; Rowe J; Peters G
Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
[TBL] [Abstract][Full Text] [Related]
5. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
6. Expression of p14ARF overcomes tumor resistance to p53.
Lu W; Lin J; Chen J
Cancer Res; 2002 Mar; 62(5):1305-10. PubMed ID: 11888896
[TBL] [Abstract][Full Text] [Related]
7. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
8. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
[TBL] [Abstract][Full Text] [Related]
9. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
Yin Y; Stephen CW; Luciani MG; Fåhraeus R
Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
[TBL] [Abstract][Full Text] [Related]
10. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
[TBL] [Abstract][Full Text] [Related]
12. MDM2-ARF complex regulates p53 sumoylation.
Chen L; Chen J
Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
[TBL] [Abstract][Full Text] [Related]
13. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar Arf sequesters Mdm2 and activates p53.
Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
[TBL] [Abstract][Full Text] [Related]
15. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
[TBL] [Abstract][Full Text] [Related]
16. Hdmx stabilizes Mdm2 and p53.
Stad R; Ramos YF; Little N; Grivell S; Attema J; van Der Eb AJ; Jochemsen AG
J Biol Chem; 2000 Sep; 275(36):28039-44. PubMed ID: 10827196
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
[TBL] [Abstract][Full Text] [Related]
18. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage.
Héron-Milhavet L; LeRoith D
J Biol Chem; 2002 May; 277(18):15600-6. PubMed ID: 11877395
[TBL] [Abstract][Full Text] [Related]
20. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]